Literature DB >> 3059471

Scenarios for a viral etiology of schizophrenia.

C B Pert1, J G Knight, P Laing, M A Markwell.   

Abstract

Recent discoveries in the field of virus receptors have revolutionized our concepts of viral pathogenesis. The lysis of cells resulting from virus infection or immune recognition of infected cells is seen as merely one facet of a spectrum of pathogenic mechanisms which may be subtle and complex. This is particularly relevant to the central nervous and immune systems which share cell-surface receptors for various neuropeptides and neurotransmitters. A number of viruses are now known to share receptors for such endogenous ligands; indeed, some viruses (e.g., human immunodeficiency virus and vaccinia) may themselves be structural analogs of these ligands. There is, therefore, considerable scope for interference by viruses in the normal functioning of the brain and neuroendocrine systems. Brief reactive psychoses are occasionally reported as acute sequels to viral infections, but generally these are regarded as unrelated to schizophrenia. An opposite viewpoint is presented in the article: i.e., that the only reason these reactive psychoses do not progress to schizophrenia is that the majority of individuals affected are not predisposed genetically to schizophrenia. Conceivably, therefore, the genetic predisposition to schizophrenia may be attributable to genes which determine idiosyncratic differences in immune responsiveness to common viral pathogens.

Entities:  

Mesh:

Year:  1988        PMID: 3059471     DOI: 10.1093/schbul/14.2.243

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  6 in total

1.  Cancer risk before schizophrenia diagnosis in Taiwan, 1995-2009.

Authors:  Yu-Jung Chen; Gen-Min Lin; Yi-Hwei Li
Journal:  Schizophr Bull       Date:  2013-05-02       Impact factor: 9.306

2.  Influenza viruses induce autoantibodies to a brain-specific 37-kDa protein in rabbit.

Authors:  P Laing; J G Knight; J M Hill; A G Harris; J S Oxford; R G Webster; M A Markwell; S M Paul; C B Pert
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

Review 3.  Genetics of schizophrenia from a clinicial perspective.

Authors:  Prachi Kukshal; B K Thelma; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Int Rev Psychiatry       Date:  2012-10

Review 4.  Measuring the costs of schizophrenia. Implications for the post-institutional era in the US.

Authors:  K G Terkelsen; A Menikoff
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

5.  Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997-2009.

Authors:  Gen-Min Lin; Yu-Jung Chen; De-Jhen Kuo; Lamin E S Jaiteh; Yi-Chung Wu; Tzu-Shun Lo; Yi-Hwei Li
Journal:  Schizophr Bull       Date:  2011-11-01       Impact factor: 9.306

6.  Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia.

Authors:  D G Kirch; R C Alexander; R L Suddath; N M Papadopoulos; C A Kaufmann; D G Daniel; R J Wyatt
Journal:  J Neural Transm Gen Sect       Date:  1992
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.